Chemotherapy
Solutions for Difficult Diagnostic Cases of Acute Exacerbations of Chronic BronchitisTsang K.W.T.Division of Respiratory and Critical Care Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: September 26, 2001
Issue release date: 2001
Number of Print Pages: 11
Number of Figures: 9
Number of Tables: 2
ISSN: 0009-3157 (Print)
eISSN: 1421-9794 (Online)
For additional information: https://www.karger.com/CHE
Abstract
Acute exacerbation of chronic bronchitis (AECB) is a very common condition, which presents with deteriorating sputum production and dyspnoea in a patient with pre-existing COPD or chronic bronchitis. As these symptoms are relatively non-specific and also the presenting feature of a wide range of other conditions, the physician should carefully consider the differential diagnosis before deciding on whether or not a patient indeed has AECB. The differential diagnosis can be summarised as pneumonia, pneumothorax, cardiac failure/cor pulmonale, bronchiectasis, asthma, tuberculosis, sinusitis and other forms of upper respiratory tract sepsis, diffuse panbronchiolitis, lung cancer, gastro-oesophageal reflux, the presence of a foreign body in the airway, melioidosis, and lung abscess. This article aims to discuss these conditions, with brief presentation of clinical cases, in the evaluation of differential diagnosis of AECB.
© 2001 S. Karger AG, Basel
Related Articles:
References
- Fuso L, Incalzi RA, Pistelli R, Muzzolon R, Valente S, Pagliari G, Gliozzi F, Ciappi G: Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med 1995;98:272–277.
-
Healthcare Cost and Utilization Project: 1997. Nationwide Inpatient Sample. Agency for Healthcare Research and Policy. Available at: www.ahcpr.gov/data/hcup/hcupnet.htm.
- Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, et al: Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995;8:1398–1420.
- American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77–S121.
-
BTS Guidelines for the management of chronic obstructive pulmonary disease: The COPD Guideline Group of the Standards of Care Committee of the BTS. Thorax 1997;52(suppl 5):S1–S28.
- Schrag SJ, Beall B, Dowell SF: Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin Microbiol Rev 2000;13:588–601.
- Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196–204.
- Murphy TF, Sethi S: Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146:1067–1083.
- Groeneveld K, Van Alphen L, Eijk PP, Visschers G, Jansen HM, Zanen HC: Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence. J Infect Dis 1990;161:512–517.
- Griffith DE, Mazurek GH: Pneumonia in chronic obstructive lung disease. Infect Dis Clin North Am 1991;5:467–484.
-
Wynne-Williams N: Bronchiectasis: A study centred on Bedford and its environs. BMJ 1953:i:1194.
- Tsang KW, Lam SK, Lam WK, Karlberg J, Wong BC, Hu WH, Yew WW, Ip MS: High seroprevalence of Helicobacter pylori in active bronchiectasis. Am J Respir Crit Care Med 1998;158:1047–1051.
- Ho PL, Chan KN, Ip MS, Lam WK, Ho CS, Yuen KY, Tsang KW: The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis. Chest 1998;114:1594–1598.
- Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H: Infective exacerbations of chronic bronchitis: Relation between bacteriologic etiology and lung function. Chest 1998;113:1542–1548.
- Ip MS, So SY, Lam WK, Yam L, Liong E: High prevalence of asthma in patients with bronchiectasis in Hong Kong. Eur Respir J 1992;5:418–423.
- Iseman MD: Tuberculosis – still the #1 killer in infectious diseases. Int J Clin Pract Suppl 2000;115:78.
- Campanella SG, Asher MI: Current controversies: sinus disease and the lower airways. Pediatr Pulmonol 2001;31:165–172.
- Tsang KW, Ooi CG, Ip MS, Lam WK, Ngan H, Chan EY, Hawkins B, Ho CS, Amitani R, Tanaka E, Itoh H: Clinical profiles of Chinese patients with diffuse panbronchiolitis. Thorax 1998;53:274–280.
- Fujii T, Kadota J, Kawakami K, Iida K, Shirai R, Kaseda M, Kawamoto S, Kohno S: Long term effect of erythromycin therapy in patients with chronic Pseudmonas aeruginosa infection. Thorax 1995;50:1246–1252.
- Storr M, Meining A, Allescher HD: Pathophysiology and pharmacological treatment of gastro-oesophageal reflux disease. Dig Dis 2000;18:93–102.
- Kiljander TO, Salomaa ER, Hietanen EK, Terho EO: Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J 2000;16:633–638.
- Chen CH, Lai CL, Tsai TT, Lee YC, Perng RP: Foreign body aspiration into the lower airway in Chinese adults. Chest 1997;112:129–133.
- Ho JCM, Ooi GC, Lam WK, Lam B, Cheung TF, Tsang KWT: Endobronchial actinomycosis associated with a foreign body. Respirology 2000;5:293–296.
- Ip M, Osterberg LG, Chau PY, Raffin TA: Pulmonary melioidosis. Chest 1995;108:1420–1424.
- Mwandumba HC, Beeching NJ: Pyogenic lung infections: Factors for predicting clinical outcome of lung abscess and thoracic empyema. Curr Opin Pulm Med 2000;6:234–239.
Article / Publication Details
Published online: September 26, 2001
Issue release date: 2001
Number of Print Pages: 11
Number of Figures: 9
Number of Tables: 2
ISSN: 0009-3157 (Print)
eISSN: 1421-9794 (Online)
For additional information: https://www.karger.com/CHE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
PubMed ID
